Larvol Delta - Cognition-Therapeutics-Presenting-New-Analyses-from-Ongoing-Clinical-Trial-of-CT1812-in-MildtoModerate-Alzheimers-Disease

Elayta (CT1812) - Cognition Therap

https://www.globenewswire.com/news-release/2022/07/19/2481724/0/en/Cognition-Therapeutics-Presenting-New-Analyses-from-Ongoing-Clinical-Trial-of-CT1812-in-Mild-to-Moderate-Alzheimer-s-Disease.html

Jul 19, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next